NANoor Azean Anis Abd Aziz

Noor Azean Anis Abd Aziz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Noor Azean Anis Abd Aziz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Effect of Leptin and Rapamycin on Sperm Count, Sperm Morphology, and Autophagy Proteins ULK1 and LC3 in Rat Testes

    by Suzanna Daud, Fayez A. Almabhouh, Harbindar Jeet Singh, Noor Azean Anis Abdul Aziz, Damayanthi Durairajanayagam

    Background: The effect of leptin and rapamycin on sperm parameters and autophagy proteins microtubule-associated protein light chain 3 (LC3) and UNC-51-like autophagy activating kinase 1 (ULK1) in rat testes was examined. Methods: For this, Sprague–Dawley rats, aged 12–14 weeks, were randomized into control, leptin-, and leptin–rapamycin (mTOR inhibitor)-treated groups. Leptin was given once daily via the intraperitoneal (IP) route at a dose of 60 [ ]g kg [ ] body weight for 14 days. Rats in the leptin–rapamycin-treated group received 60 [ ]g and 2 mg kg [ ] body weight of leptin and rapamycin, respectively (IP), for 14 days. Controls received 0.1 mL of normal saline (IP). On day 15, the rats were euthanized, and testes and epididymides were collected for sperm count, sperm morphology, LC3, and ULK1 estimation. Data were analyzed using ANOVA. Results: Sperm count was significantly lower, while the fraction of spermatozoa with abnormal morphology was significantly higher in leptin- and leptin–rapamycin-treated rats compared to controls. No significant differences were evident in LC3 and ULK1 levels in testicular tissues between the three groups of rats. Conclusions: It appears that the adverse effects of leptin on sperm and testes in the rat may not involve the mTOR pathway or reduced autophagy.

  • Open Access

    Tocotrienol-rich fraction supplementation prevents foetal loss in females mated with corticosterone-treated male Sprague-Dawley rats

    by Noor Azean Anis Abd Aziz, Amar Chatterjee, Rita Chatterjee, Damayanthi Durairajanayagam

    This study examined whether tocotrienol supplementation to corticosterone‐treated male rats could prevent foetal loss in females upon their mating. Epididymides of adult male Sprague–Dawley (SD) rats with proven fertility were surgically separated at the testis‐caput junction. Twenty‐four hours post‐surgery, these animals received for 7 days either: tocopherol‐stripped corn oil (Control), corticosterone 25 mg/kg s.c. (CORT), CORT 25 mg/kg s.c. and tocotrienol‐rich fraction (TRF) 100 mg/kg orally (CORT + TRF) or TRF 100 mg/kg orally (TRF). On day 8, males were cohabited with proestrus females. A spermatozoa‐positive vaginal smear indicated pregnancy. Males were euthanised for analysis of testosterone and antioxidant activities. Reproductive organs were weighed. On day 8 of pregnancy, females were laparotomised to count the number of implantation sites. Pregnancy was continued until term. Number of pups delivered and their weights were determined. Data were analysed using ANOVA. Malondialdehyde levels were significantly lower in CORT + TRF group compared with CORT group. Enzymatic antioxidant activities, testosterone level and reproductive organ weights were significantly higher in CORT + TRF group compared with CORT group. Number of implantation sites and live pups delivered, and their birth weights from females mated with CORT + TRF males were significantly higher compared to CORT group. Therefore, TRF prevents foetal loss in females mated with CORT + TRF‐treated males.


  • LY294002, a PI3K pathway inhibitor, prevents leptin-induced adverse effects on spermatozoa in Sprague-Dawley rats

    by Amir Hafidz Md Mokhtar, Ifrah Alam Malik, Noor Azean Anis Abd Aziz, Fayez A. Almabhouh, Damayanthi Durairajanayagam, Harbindar Jeet Singh

    This study examined the effects of PI3K and AMPK signalling pathway inhibitors on leptin‐induced adverse effects on rat spermatozoa. Sprague‐Dawley rats, aged 14–16 weeks, were randomised into control, leptin‐, leptin + dorsomorphin (AMPK inhibitor)‐, and leptin+LY294002 (PI3K inhibitor)‐treated groups with six rats per group. Leptin was given once daily for 14 days via the intraperitoneal (i.p.) route at a dose of 60 ug kg−1 body weight. Rats in the leptin and inhibitor‐treated groups received concurrently either dorsomorphin (5 mg kg−1 day−1) or LY294002 (1.2 mg kg−1 day−1) i.p. for 14 days. Controls received 0.1 ml of normal saline. Upon completion, sperm count, sperm morphology, seminiferous tubular epithelial height (STEH), seminiferous tubular diameter (STD), 8‐hydroxy‐2‐deoxyguanosine (8‐OHdG) and phospho‐Akt/total Akt ratio were estimated. Data were analysed using ANOVA. Sperm count, STEH and STD were significantly lower, while the percentage of spermatozoa with abnormal morphology and the level of 8‐OHdG were significantly higher in rats treated with leptin and leptin + dorsomorphin when compared to those in controls and LY294002‐treated rats. Testicular phospho‐Akt/total Akt ratio was significantly higher in leptin and leptin + LY294002‐treated rats. In conclusion, LY294002 prevents leptin‐induced changes in rat sperm parameters, suggesting the potential role of the PI3K signalling pathway in the adverse effects of leptin on sperm parameters.